Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler
Completed
- Conditions
- Asthma
- Registration Number
- NCT00524641
- Lead Sponsor
- AstraZeneca
- Brief Summary
To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6 weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1254
Inclusion Criteria
- Asthma patients from both sexes, age 18 or older
- Have already been on Symbicort SMART treatment
- Willing to give written informed consents to participate in the program.
Read More
Exclusion Criteria
- Patients who are not willing to give written informed consent
- Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇻🇳Ho Chi Minh City, Vietnam